Related Experiment Videos
Determination of the age-related changes of serum basic fibroblast growth factor (bFGF) level in healthy Japanese
Yoshihiro Okamoto1, Mayuri Tanaka, Nobuhiro Miyahara
1Laboratory of Immunology and Microbiology, Faculty of Pharmacy, Chiba Institute of Science, 3 Shiomi-cho, Choshi, Chiba 288-0025, Japan. yokamoto@cis.ac.jp
Insights
Serum basic fibroblast growth factor (bFGF) levels were established for healthy Japanese individuals. No significant differences were found between children and adults, but children
Area of Science:
- Biochemistry
- Pediatrics
- Clinical Chemistry
Background:
- Serum basic fibroblast growth factor (bFGF) is a crucial protein involved in cell growth and repair.
- Establishing reliable reference values for bFGF is essential for clinical diagnostics, particularly in pediatric cases.
- Previous studies have not comprehensively defined age-specific reference ranges for bFGF in healthy populations.
Purpose of the Study:
- To determine the serum bFGF levels in healthy Japanese individuals to establish reference values.
- To compare serum bFGF levels between children and adults.
- To validate the clinical utility of established bFGF reference values in a pediatric patient with Hemolytic Uremic Syndrome (HUS).
Main Methods:
- Serum samples from healthy Japanese individuals (children and adults) were analyzed using a specific human bFGF ELISA (Enzyme-Linked Immunosorbent Assay).
- Statistical analyses were performed to compare bFGF levels between age groups and to determine reference ranges.
- Serum bFGF levels of a pediatric patient with diarrhea-positive (D+) HUS were measured and compared to healthy controls.
Main Results:
- No significant differences in serum bFGF levels were observed between healthy children and adults.
- The reference value range for serum bFGF was broader in children compared to adults.
- The pediatric HUS patient exhibited markedly elevated serum bFGF levels from the onset of the condition compared to healthy children.
Conclusions:
- Established reference values for serum bFGF in healthy Japanese individuals are now available.
- Age-matched controls are recommended for accurate evaluation of patient serum bFGF levels.
- The study highlights the potential of serum bFGF levels as a biomarker for distinguishing normal physiological states from pathological conditions like pediatric HUS.
Abstract:
We determined the serum basic fibroblast growth factor (bFGF) levels in healthy Japanese individuals to establish a reference value by means of specific human bFGF ELISA. It was found that there were no significant differences between the serum bFGF levels of children and adults. However, the reference value for children had a broader range than that of adults. Therefore, it is recommended that when the serum bFGF levels of patients are evaluated, the values should be compared with those of age-matched controls. To demonstrate the usefulness of the reference value for children, we measured the bFGF level of an 8-year boy with diarrhea positive (D+) hemolytic uremic syndrome (HUS), as a preliminary study. The serum bFGF level of the patient with HUS was markedly higher than those of healthy children from the onset of D+HUS. Our reliable reference value for healthy children will allow us to discriminate between normal and pathological conditions in future studies.